期刊
FUTURE ONCOLOGY
卷 14, 期 14, 页码 1335-1338出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2018-0116
关键词
checkpoint inhibitors; IMCgp100; immunotherapy; MEK inhibitors selumetinib; tumor infiltrating lymphocytes; uveal melanoma